Disclaimer: The TipRanks Smart Score performance is based on backtested results. Backtested performance is not an indicator of future actual results. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. Backtested results are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. General assumptions include: XYZ firm would have been able to purchase the securities recommended by the model and the markets were sufficiently liquid to permit all trading. Changes in these assumptions may have a material impact on the backtested returns presented. Certain assumptions have been made for modeling purposes and are unlikely to be realized. No representations and warranties are made as to the reasonableness of the assumptions. This information is provided for illustrative purposes only. Backtested performance is developed with the benefit of hindsight and has inherent limitations. Specifically, backtested results do not reflect actual trading or the effect of material economic and market factors on the decision-making process. Since trades have not actually been executed, results may have under- or over-compensated for the impact, if any, of certain market factors, such as lack of liquidity, and may not reflect the impact that certain economic or market factors may have had on the decision-making process. Further, backtesting allows the security selection methodology to be adjusted until past returns are maximized. Actual performance may differ significantly from backtested performance. Backtested results are adjusted to reflect the reinvestment of dividends and other income and, except where otherwise indicated, are presented gross-of fees and do not include the effect of backtested transaction costs, management fees, performance fees or expenses, if applicable. Please note all regulatory considerations regarding the presentation of fees must be taken into account. No cash balance or cash flow is included in the calculation.
FAQs
Vermilion Energy (VET) Stock Forecast, Price Targets and Analysts Predictions - TipRanks.com? ›
Based on short-term price targets offered by 10 analysts, the average price target for Vermilion Energy comes to $15.10. The forecasts range from a low of $12.60 to a high of $17.25. The average price target represents an increase of 60.81% from the last closing price of $9.39.
What is the forecast for Vermilion Energy? ›VET Stock 12 Month Forecast
Based on 7 Wall Street analysts offering 12 month price targets for Vermilion Energy in the last 3 months. The average price target is $15.19 with a high forecast of $16.08 and a low forecast of $14.62. The average price target represents a 34.54% change from the last price of $11.29.
The average price target represents 34.24% Increase from the current price of C$15.45. Vermilion Energy's analyst rating consensus is a Moderate Buy. This is based on the ratings of 7 Wall Streets Analysts.
What is the future of Vermilion stock? ›Future Growth
Vermilion Energy is forecast to grow earnings and revenue by 87.2% and 1.2% per annum respectively while EPS is expected to grow by 110.2% per annum.
Wall Street analysts forecast WELL stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for WELL is 7.77 CAD with a low forecast of 5.05 CAD and a high forecast of 10.5 CAD.
What is Vermilion price prediction? ›Based on short-term price targets offered by 10 analysts, the average price target for Vermilion Energy comes to $15.10. The forecasts range from a low of $12.60 to a high of $17.25. The average price target represents an increase of 68.9% from the last closing price of $8.94.
What is Vermilion Energy dividend news? ›("Vermilion") (TSX: VET) (NYSE: VET) is pleased to announce a cash dividend of $0.12 CDN per share, payable on October 15, 2024 to all shareholders of record on September 27, 2024. This dividend is an eligible dividend for the purposes of the Income Tax Act (Canada).
Why is Vermilion Energy going down? ›It has exposure to European gas and has had excess profits. European governments decided to tax these profits so this brought the share price down.
How much debt is Vermilion Energy in? ›Net debt(6) decreased by $38 million in Q2 2024 to $907 million, representing a net debt to trailing FFO ratio(7) of 0.7 times and the lowest debt level in over a decade.
What is the best energy company to invest in? ›| Company and ticker symbol | Performance in 2024 |
|---|---|
| Kinder Morgan (KMI) | 22.3% |
| Marathon Petroleum (MPC) | 19.4% |
| Marathon Oil (MRO) | 18.6% |
| Exxon Mobil (XOM) | 18.0% |
What is Vermilion Energy dividend payout ratio? ›
Does Vermilion Energy have sufficient earnings to cover their dividend? Yes, TSE:VET's past year earnings per share was -C$3.77, and their annual dividend per share is C$0.44. TSE:VET's dividend payout ratio is -11.62% (C$0.44/-C$3.77) which is not sustainable.
What does Vermilion Energy do? ›Vermilion operates globally, with oil and gas properties onshore and offshore. Our diversified asset base provides a measure of stability for investors.
What is the forecast for align stock in 2025? ›On average, Wall Street analysts predict that Align Technology's share price could reach $320.00 by Sep 13, 2025. The average Align Technology stock price prediction forecasts a potential upside of 31.29% from the current ALGN share price of $243.73.
How do you know if a stock will go up? ›If more people want to buy a stock (demand) than sell it (supply), then the price moves up. Conversely, if more people wanted to sell a stock than buy it, there would be greater supply than demand, and the price would fall.
What is the well health stock prediction for 2024? ›Analysts tracking Well Health expect sales to rise by 23% to $956 million in 2024 and by 9.7% to $1.05 billion in 2025. Comparatively, its bottom line is forecast to improve from a loss per share of $0.03 in 2024 to earnings per share of $0.17 in 2025.
Is WELL a buy, sell, or hold? ›WELL Health Technologies Corp's analyst rating consensus is a Strong Buy. This is based on the ratings of 7 Wall Streets Analysts.
What is the lke forecast for 2025? ›According to analysts, LKE price target is 0.10 AUD with a max estimate of 0.14 AUD and a min estimate of 0.05 AUD.
What is the price target for Leslie's stock? ›The average price target for Leslie's is $3.39. This is based on 11 Wall Streets Analysts 12-month price targets, issued in the past 3 months. The highest analyst price target is $4.00 ,the lowest forecast is $2.25. The average price target represents 13.76% Increase from the current price of $2.98.